Pharmacokinetics of 2-(p-methylallylaminophenyl) propionic acid, alminoprofene, in man after single and multiple oral doses. 1980

A Premel-Cabic, and P Allain, and L Pidhorz, and G Streichenberger

2-(p-methylallylaminophenyl) propionic acid, alminoprofene (INN), a new antalgic drug, was administered orally to men as a single (300 mg) and multiple doses (300 mg three times daily). Plasma and urine concentrations of alminoprofene were determined by gas-liquid chromatography. After the single oral dose, the peak plasma level (36.2 to 41.5 mg/l) was reached within 0.5 -1.5 h. the biological half-life ranged from 2.5 to 3.2 h. During chronic administration of alminoprofene, steady-state equilibrium was established within 24 h. The urinary excretion of alminoprofene as unchanged product and as glucuronide was very important.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011422 Propionates Derivatives of propionic acid. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxyethane structure. Propanoate,Propanoic Acid,Propionate,Propanoates,Propanoic Acid Derivatives,Propanoic Acids,Propionic Acid Derivatives,Propionic Acids,Acid, Propanoic,Acids, Propanoic,Acids, Propionic,Derivatives, Propanoic Acid,Derivatives, Propionic Acid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000700 Analgesics Compounds capable of relieving pain without the loss of CONSCIOUSNESS. Analgesic,Anodynes,Antinociceptive Agents,Analgesic Agents,Analgesic Drugs,Agents, Analgesic,Agents, Antinociceptive,Drugs, Analgesic

Related Publications

A Premel-Cabic, and P Allain, and L Pidhorz, and G Streichenberger
December 1977, European journal of clinical pharmacology,
A Premel-Cabic, and P Allain, and L Pidhorz, and G Streichenberger
September 1988, International journal of clinical pharmacology, therapy, and toxicology,
A Premel-Cabic, and P Allain, and L Pidhorz, and G Streichenberger
January 1980, Therapie,
A Premel-Cabic, and P Allain, and L Pidhorz, and G Streichenberger
May 1988, Arzneimittel-Forschung,
A Premel-Cabic, and P Allain, and L Pidhorz, and G Streichenberger
August 1995, Journal of clinical pharmacology,
A Premel-Cabic, and P Allain, and L Pidhorz, and G Streichenberger
March 2006, Journal of clinical pharmacology,
A Premel-Cabic, and P Allain, and L Pidhorz, and G Streichenberger
October 1982, Acta pharmacologica et toxicologica,
A Premel-Cabic, and P Allain, and L Pidhorz, and G Streichenberger
January 1974, European journal of clinical pharmacology,
A Premel-Cabic, and P Allain, and L Pidhorz, and G Streichenberger
April 1986, Arzneimittel-Forschung,
A Premel-Cabic, and P Allain, and L Pidhorz, and G Streichenberger
January 2007, Pulmonary pharmacology & therapeutics,
Copied contents to your clipboard!